Table of Contents
Cancers, Volume 10, Issue 6 (June 2018)
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story (view full-size image) Until today, older patients with high-risk myelodysplastic syndrome (MDS) and acute myeloid [...] Read more. Until today, older patients with high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) have poor outcomes when treated with conventional treatment strategies. Response after a first-line treatment with hypomethylating agents (HMA) occurs in less than 50% of these patients. In our review, we focus on upcoming new treatment strategies in the field of HMA-based combination strategies. One of the current most promising approaches is preventing HMA resistance by using checkpoint inhibitors. We are sure that these new treatment options will guide the future of clinical research. Recent data also suggest a potential renaissance of intensive treatment strategies, such as therapies based on CPX-351. View this paper.